ConductScience.org, home

Paper1102002

Principles of combination therapy.

Levin S and 1 other. Bull N Y Acad Med, 1975. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Principles of combination therapy. Papers, record 1102002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1102002

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Principles of combination therapy.
PubMed
Journal
Bull N Y Acad Med
PubMed
Year
1975
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.29
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Levin SS
2Harris AAA A

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Infective AgentsMajor topic
Bacterial InfectionsMajor topic
Drug Therapy, CombinationMajor topic
Anti-Bacterial Agents
Dose-Response Relationship, Drug
Drug Antagonism
Drug Synergism
Endocarditis, Bacterial
Humans
Pseudomonas Infections
Sulfamethoxazole
Trimethoprim

Source PubMed

Download CSV of topics

References89

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14180218Resistance of Pseudomonas aeruginosa to carbenicillin.Lancet1969https://conductscience.org/library/papers/4180218PubMed
24188384Fusidic acid and lincomycin therapy in staphylococcal infections in cystic fibrosis.Lancet1970https://conductscience.org/library/papers/4188384PubMed
34374476Modification of human neutrophil response to endotoxin with polymyxin B sulfate.J Infect Dis1974https://conductscience.org/library/papers/4374476PubMed
44382581Studies on the pathogenesis of meningitis. VI. Antagonism between penicillin and chloramphenicol in experimental pneumococcal meningitis.J Lab Clin Med1967https://conductscience.org/library/papers/4382581PubMed
54357095Pseudomonas cepacia tricuspid endocarditis: treatment with trimethoprim, sulfonamide, and polymyxin B.J Infect Dis1973https://conductscience.org/library/papers/4357095PubMed
64316000The synergistic action of the sulfonamides and the polymyxins against Serratia marcescens.J Infect Dis1970https://conductscience.org/library/papers/4316000PubMed
74306976Gram-negative rod bacteremia.J Infect Dis1969https://conductscience.org/library/papers/4306976PubMed
84579141In vivo antagonism between gentamicin and chloramphenicol in neutropenic mice.J Infect Dis1973https://conductscience.org/library/papers/4579141PubMed
94596743Clinical significance of in vitro synergism between antibiotics in gram-negative infections.Antimicrob Agents Chemother1972https://conductscience.org/library/papers/4596743PubMed
104599860Synergistic action of ampicillin and erythromycin against Nocardia asteroides: effect of time of incubation.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4599860PubMed
114550233Interactions among antibiotics and other drugs.JAMA1972https://conductscience.org/library/papers/4550233PubMed
124491548Interactions between fusidic acid and penicillins.J Med Microbiol1973https://conductscience.org/library/papers/4491548PubMed
134490252Antibiotic synergism against group D streptococci in the treatment of endocarditis.Med J Aust1973https://conductscience.org/library/papers/4490252PubMed
144489479Comparison of treatments with several antibiotics in experimental infections due to methicillin-resistant Staphylococcus aureus.J Infect Dis1972https://conductscience.org/library/papers/4489479PubMed
154462463Combined amphotericin B-tetracycline therapy for experimental coccidioidomycosis.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4462463PubMed
164816171Chronic mucocutaneous candidiasis: immunologic and antibiotic therapy.Ann Intern Med1974https://conductscience.org/library/papers/4816171PubMed
174791489Successful treatment of Pseudomonas cepacia endocarditis with trimethoprim-sulfamethoxazole.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4791489PubMed
184823583Penicillin-aminoglycoside synergy in experimental Streptococcus viridans endocarditis.J Infect Dis1974https://conductscience.org/library/papers/4823583PubMed
194758830Bactericidal effect of combinations of nalidixic acid and various antibiotics on Enterobacteriaceae.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4758830PubMed
204758061Trimethoprim-sulfamethoxazole. Summary and comments on the conference.J Infect Dis1973https://conductscience.org/library/papers/4758061PubMed

See all 89 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
39345262Current and emerging approaches for eliminating Borrelia burgdorferi and alleviating persistent Lyme disease symptoms.Front Microbiol2024https://conductscience.org/library/papers/39345262PubMed
37899968A mechanistic assessment of the nature of pharmacodynamic drug-drug interaction in vivo and in vitro.In Silico Pharmacol2023https://conductscience.org/library/papers/37899968PubMed
37138535Potential clinical value of catheters impregnated with antimicrobials for the prevention of infections associated with peritoneal dialysis.Expert Rev Med Devices2023https://conductscience.org/library/papers/37138535PubMed
32123189Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31.Sci Rep2020https://conductscience.org/library/papers/32123189PubMed
30816136Comparison of null models for combination drug therapy reveals Hand model as biochemically most plausible.Sci Rep2019https://conductscience.org/library/papers/30816136PubMed
26014929Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/26014929PubMed
25121020Burden of antibiotic resistance in common infectious diseases: role of antibiotic combination therapy.J Clin Diagn Res2014https://conductscience.org/library/papers/25121020PubMed
16033288Antifungal combination therapy: clinical potential.Drugs2005https://conductscience.org/library/papers/16033288PubMed
879749In vitro synergism between carbenicillin and aminoglycosidic aminocyclitols against Acinetobacter calcoaceticus var. anitratus.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/879749PubMed
646344Quantitation of antibiotics by high-pressure liquid chromatography: cephalothin.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/646344PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1102002

GET https://conductscience.org/api/papers/v1/1102002/references?page=2